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INTRODUCTION
In recent years, due to uncritical use of carbapenems in the Intensive Care Unit (ICU), there are numerous reports of a progressive increase in the incidence of severe and lifethreatening hospital infections (HIs) by gram-negative bacteria that are resistant to these antibiotics. An important example of such a microorganism is the carbapenem-resistant Klebsiella pneumoniae (CR-Kp), which has become a major threat to hospitals, increasing mortality, length of stay, and cost (1) (2) (3) (4) . An additional difficulty is the multi-resistant nature of such isolates, which further complicates the treatment of HIs due to limited choices for effective antibiotics.
Recent studies shed light on some risk factors for CR-Kp acquisition (5) (6) (7) (8) . However, the importance of the prior use of antibiotics has been little investigated. Modern medicine requires additional knowledge for prevention of these infections and for the optimal choice of empirical antibiotic therapy.
The aim of our study was to discover the risk factors for the development of HIs caused by CR-Kp. These may be crucial for implementing efficient infection control measures to decrease the spread of these pathogens. In addition, this study analysed the sensitivity of isolates to the most frequently used antibiotics.
MATERIALS AND METHODS
Hospital settings and the study population
This study was conducted in the 18-bed Medical-Surgical ICU of the Clinical Centre Kragujevac, Kragujevac, Serbia, during the 5-year period from January 1, 2011, to December 31, 2015. The inclusion criteria for the study participants were (a) a stay in the ICU >48 hours, (b) development of HIs caused by Klebsiella pneumoniae with any localization and (c) age >18 years. The exclusion criteria were (a) isolation of pathogens within 48 hours of admission and (b) repeated sampling from the same location of infection.
Study design and definition of the study groups
A prospective cohort study design was used that involved construction of two study groups. The "cases" were patients with HIs caused by CR-Kp, while the "controls" were patients infected with carbapenem-sensitive Klebsiella pneumoniae (CS-Kp).
Microbiology and susceptibility testing
The isolates were identified to the species level using conventional biochemical methods in the Microbiology Laboratory of Clinical Centre Kragujevac (9) . Antimicrobial susceptibilities were determined by the disk diffusion method or with a Vitek-2 automated system (BioMerieux, France) for the following antibiotics: amoxicillin+clavulanic acid (30 μg/mL), piperacillin-tazobactam (110 μg/mL), cefotaxime (30 μg/mL), ceftriaxone (30 μg/mL), ceftazidime (30 μg/mL), cefepime (30 μg/mL), imipenem (10 μg/mL), meropenem (10 μg/mL), gentamicin (10 μg/mL), amikacin (30 μg/mL), ciprofloxacin (5 μg/mL), trimethoprimsulfamethoxazole (2.5 μg/mL) and tigecycline (15 μg/mL). All isolates with intermediate sensitivity or resistance to the tested antibiotic were considered resistant. The results were interpreted according to the guidelines issued by The Clinical and Laboratory Standards Institute (CLSI) (10) .
CR-Kp was determined if Klebsiella pneumoniae isolates were resistant to both tested carbapenems (imipenem and meropenem). In cases of discrepancy, imipenem resistance served as the reference. According to the latest recommendations, multi-resistance was defined as acquired non-susceptibility to at least one agent from three or more different antibiotic groups, and pan-resistance as non-susceptibility to all antimicrobial categories (11) .
Definition HIs and data collection
Diagnosis and anatomical localization of HIs caused by Klebsiella pneumoniae were determined by the Centers for Disease Control (CDC) criteria (12) . Surveillance of HIs included daily clinical examination of patients and daily review of the patients' medical records. To exclude the patients colonized with Klebsiella pneumoniae, each of the cases was analysed by an independent expert group composed of an infectologist, epidemiologist, specialist of intensive medicine and clinical pharmacologist. The patients were followed to the final outcome, either cure and discharge from the hospital or death.
Patient data and potential risk factors were extracted from the medical records and the recording order on the standardized questionnaire for each patient, which had two sets of data:
a. related to patient characteristics: demographics (age and gender) and co-morbid conditions (hypertension, diabetes mellitus, cancer of different localization, injury), and b. related to health care: urgent admission, dates of admission and discharge (to the hospital and to the ICU), diagnostic and therapeutic procedures performed (venous catheters, mechanical ventilation, surgery within a month), date of the first isolation of positive Klebsiella pneumoniae culture, and data about administered antibiotics. Prior exposure to antibiotics was defined as administration of a systemic antimicrobial agent for at least 24 hours during the 14-day period before isolation of Klebsiella pneumoniae. The Ethics Committee of the health institution approved the study.
Statistical analysis
The data obtained were processed using descriptive statistics with measures of central tendency (mean), variability (standard deviation from the mean) and relative numbers. The significance of differences in the values of the continuous variables between the study groups was tested by Student's T-test for independent samples. The chi-square test or Fisher's test (for values in cells of contingency tables lower than 5 or zero) were used for comparison of categorical variables between the groups. Independent variables detected as significant predictors in univariate analysis were later entered into the multivariate logistic regression model. The hypotheses were tested at the 0.05 level of statistical significance. All calculations were performed using SPSS (Statistical Package for Social Science for Windows) software, version 18.
RESULTS
During the study period in the ICU, there were 105 patients who developed HIs caused by Klebsiella pneumoniae, according to the pre-defined criteria. Three-quarters were male (n=78; 74.3%) and the average age of the patients was 59.37±15.37 years (range 20-85 years). In 68 patients (64.8%), the HIs were caused by CR-Kp, while 37 (35.2%) of the HIs were caused by CR-Kp. The predominant anatomical location of infection in both groups was The difference between study groups relative to the site of HIs was not statistically significant (p>0.05) ( Table 1) . Table 2 shows the results of the univariate analysis of potential risk factors for HIs caused by CR-Kp relative to clinical characteristics, invasive procedures and prior therapy. According to this analysis, risk factors significantly associated with the development of these infections were co-morbidities such as cancer or concomitant HIs, the use of invasive medical procedures such as placement of central venous catheter or mechanical ventilation or surgical intervention, a prolonged stay in hospital/ICU, the use of antibiotics before emergence of infection, and previous administration of carbapenems, aminoglycosides, ciprofloxacin, vancomycin or metronidazole (p<0.05).
Multivariate logistic regression identified five independent risk factors for CR-Kp infections: the use of mechanical ventilation (OR=6.090; 95% CI=1.030-36.020; p=0.046), length of antibiotic therapy before HIs (days) (OR=1.080; 95% CI=1.003-1.387; p=0.045), and previous use of carbapenems (OR=7.005; 95% CI=1.054-46.572; p=0.044), ciprofloxacin (OR=20.628; 95% CI=2.292-185.687; p=0.007) and metronidazole (OR=40.320; 95% CI=2.347-692.795; p=0.011) ( Table 3 ). The Hosmer-Lemeshow Goodnessof-Fit Test for this logistic regression model was χ 2 =5.223; p=0.734.
Resistance rates (%) of the tested isolates of Klebsiella pneumoniae to other antibiotics are shown in Table 4 . For the majority of antibiotics, it was over 85%, except for piperacillintazobactam (59.8%) and tigecycline (14.0%). However, isolates of CR-Kp had a significantly higher incidence of resistance to the following antibiotics than the CS-Kp isolates: piperacillintazobactam (80.4% vs. 25.8% respectively; p<0.001), amikacin (93.7% vs. 71.4% respectively; p=0.003), ciprofloxacin (98.4% vs. 80.0% respectively; p=0.001) and trimethoprim-sulfamethoxazole (95.0% vs. 76.2% respectively; p=0.029). Nearly two-thirds of the isolates were multi-resistant (n=67; 63.8%), while 7 (6.7%) were pan-resistant.
Lethal outcomes occurred in the 36 (52.9%) patients with CR-Kp and 14 (37.8%) with CS-Kp infections, but the difference was not statistically significant (p=0.139).
In this period, the outbreaks of HIs caused by Klebsiella pneumoniae were not recorded. 
DISCUSSION
Klebsiella pneumoniae has become an important challenge in health-care settings due to its frequency in HIs and the incidence of resistance to the entire spectrum of antibiotics (13) . We still do not know what predisposes patients to acquire infections with resistant strains of Klebsiella pneumoniae. Therefore, we conducted a prospective cohort study to analyse the association between numerous potential risk factors and HIs caused by CR-Kp among patients in the ICU. Most previous studies were retrospective, which imposed a bias in the interpretation of the results (differentiation between infection and colonization), and data derived from mixed medical and critical care populations are biased because the prevalence of patients was small. Our study showed that the CR-Kp is essentially a "healthcare-associated infection". Multivariate analysis pointed to five significant risk factors, none of which were patient-related.
When overviewing the role of invasive medical procedures in the development HIs caused by CR-Kp, only mechanical ventilation emerged as an independent risk factor, which was expected because previous studies also pointed to this factor (14) . According to our results, mechanical ventilation increased the risk of these infections 6.1-fold (95% CI=1.030-36.020; p=0.046). Patients in the ICU often require mechanical ventilation due to respiratory failure, poor gas exchange, and lung and neurologic injury, but this procedure also opens the pathway for the entrance of infectious agents. Microorganisms from the environment adhere to respiratory support equipment and form a biofilm, which is out of reach of antibiotics and neutrophils. Patients with unrecognized CR-Kp colonization are especially important since they are reservoirs for the further transmission of these bacteria (15, 16) . To reduce these infections, it is prudent to use non-invasive ventilation instead, such as nasal continuous positive pressure ventilation or nasal synchronized intermittent mandatory ventilation.
Previous exposure to antibiotics is often associated with the occurrence of HIs caused by resistant pathogens. For this research, it was defined as at least 24 hours of therapy with antibiotics within 14 days before the isolation of Klebsiella pneumoniae. Multivariate analysis showed that the duration of the previous use of antibiotics was associated with a risk of CR-Kp infection. Longer exposure to antimicrobial therapy can be considered an additional factor in the destruction of protective barriers because it promotes colonization and infection by drug-resistant pathogens. The selection of these strains contributes to the broad-spectrum antibiotics widely used in many ICUs. In patients with prolonged antimicrobial therapy, normal microbiological flora are replaced with endemic bacterial strains from the hospital environment, which are often multi-resistant.
In our study, previous exposure to carbapenems predisposed patients for HIs caused by CR-Kp by 7.0-fold (95% CI=1.054-46.572; p=0.044) consistent with the results of previous studies (17, 18) . According to the case-control study by Wu and associates (14) , an independent risk factor for contracting CP-Kp infection is the previous use of carbapenems (OR=12.69, 95% CI=2.09-77.10; p=0.006). These beta-lactam antibiotics with broad-spectrum activity destroy the susceptible bacterial strains that colonized patients and facilitate the selection of multi-resistant pathogens.
Introduction of a new generation of fluoroquinolones with improved activity against respiratory pathogens and improved pharmacokinetics led to the wide use of these antibiotics for empirical therapy in critically ill patients. However, we must better understand their role in the development of bacterial resistance. Our study showed that the risk of HIs caused by CR-Kp after the use of ciprofloxacin was 20.6-fold higher (95% CI=2.292-185.687; p=0.007). Schwaber and associates (19) found that the prior use of fluoroquinolones was related to CR-Kp isolation, and only the strength of association was low (OR=7.2, 95% CI=1.1-49.4; p=0.04). This should be considered when evaluating the potential benefits and harms of administering ciprofloxacin to patients in the ICU.
The previous use of metronidazole is also associated with HIs caused by CR-Kp, which is of broad relevance since it is frequently used in patients residing in the ICU. Metronidazole decreases the burden of anaerobic bacteria and creates room for invasion by multi-resistant hospital flora, including Klebsiella pneumoniae.
Broad-spectrum antibiotics select multi-resistant bacterial strains because they eradicate concurrent, yet sensitive, microorganisms. However, in our study, previous use of piperacillin-tazobactam, second-and thirdgeneration cephalosporins, aminoglycosides or vancomycin were not associated with HIs caused by CR-Kp, after adjustment for other variables (aminoglycosides and vancomycin showed significant influences when taken separately, at p=0.022 and p=0.003, respectively). The finding is unexpected, considering the generally accepted link between antimicrobial use and resistant bacteria. This should probably be attributed to the recent administration of a variety of agents to the majority of patients included in the study. Some recent studies have presented results similar to ours (5). All of this suggests that the correlation between antimicrobial use and resistance is a much more complex phenomenon.
Klebsiella pneumoniae became resistant to almost all available antimicrobial agents (20) . This is alarming because a high resistance rate for most tested antibiotics was recorded (over 85%), while only tigecycline sensitivity was still preserved (rate of resistance is 14.0%). In addition, two-thirds of isolates were multi-resistant (63.8%). In a recent study similar to ours (21), the rates of antibiotic resistance were lower, as were the percentages of multiand pan-resistant isolates (47.1% and 1.2%). Treatment of patients with these infections is prolonged, expensive and bears increased mortality (22) .
An especially worrying result of this study is the high rate of carbapenem-resistant isolates (n=78; 74.3%). These antibiotics are often used as a drug of last resort in combating gram-negative infections that are resistant to other antibiotics. The most important mechanism of resistance of carbapenems is the production of a carbapenemase enzyme, blaKPC. The gene for this enzyme is carried on a mobile piece of genetic material, which increases the risk for dissemination, even to other Enterobacteriaceae (23, 24) . The emergence and spread of CR-Kp underlines the need for immediate aggressive detection and control strategies to preserve their efficacy in the future (25) .
In conclusion, HIs caused by CR-Kp are strongly associated with the use of mechanical ventilation and the duration of the previous use of certain antibiotics (carbapenems, ciprofloxacin and metronidazole). These results should help doctors to identify at-risk patients to implement measures to prevent the onset of CR-Kp infections. The results can also contribute to crafting appropriate institutional policy for antibiotics utilization and the development of effective strategies for the prevention of these infections.
